Envista (NVST) Scheduled to Post Earnings on Wednesday

Envista (NYSE:NVST) will be releasing its earnings data after the market closes on Wednesday, May 1st. Analysts expect Envista to post earnings of $0.31 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.04). The business had revenue of $645.60 million during the quarter, compared to the consensus estimate of $638.37 million. Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.52 earnings per share. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Envista Trading Up 0.6 %

Shares of NYSE:NVST opened at $20.23 on Wednesday. The company has a current ratio of 2.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.33. Envista has a 1 year low of $18.95 and a 1 year high of $39.28. The firm has a fifty day moving average price of $21.08 and a 200 day moving average price of $22.79. The stock has a market capitalization of $3.48 billion, a PE ratio of -33.16, a P/E/G ratio of 3.73 and a beta of 1.35.

Wall Street Analysts Forecast Growth

NVST has been the subject of a number of recent analyst reports. TheStreet cut shares of Envista from a “c” rating to a “d+” rating in a report on Wednesday, February 7th. Jefferies Financial Group cut shares of Envista from a “buy” rating to a “hold” rating and reduced their target price for the company from $30.00 to $23.00 in a research note on Friday, February 9th. SVB Leerink assumed coverage on shares of Envista in a research note on Monday, February 26th. They issued an “underperform” rating and a $19.00 target price for the company. Leerink Partnrs reiterated an “underperform” rating on shares of Envista in a research note on Monday, February 26th. Finally, UBS Group began coverage on shares of Envista in a research note on Friday, January 5th. They issued a “neutral” rating and a $26.00 target price for the company. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $29.60.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.